Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karger Publishers
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:233a25bf3d4949f692b2b338038fcfc1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:233a25bf3d4949f692b2b338038fcfc12021-12-02T12:40:23ZMalignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection2296-970510.1159/000520399https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc12021-11-01T00:00:00Zhttps://www.karger.com/Article/FullText/520399https://doaj.org/toc/2296-9705Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very high serum titer of anti-PLA2R autoantibodies in a patient with a synchronous diagnosis of poorly differentiated esophageal adenocarcinoma and renal cell carcinoma who presented with nephrotic syndrome. Based on the current classification, MN in the presence of active malignancy is diagnosed as secondary and unlikely to have positive anti-PLA2R autoantibodies. This raises several questions: whether this patient has secondary MN associated with malignancy and coincidentally discovered anti-PLA2R autoantibodies, primary MN due to anti-PLA2R autoantibodies with coincidentally discovered malignancy, or whether malignancy can induce the formation of anti-PLA2R autoantibodies that result in MN. This case report highlights the importance of age-appropriate cancer screening, even in patients with presumed primary MN and positive anti-PLA2R autoantibodies.Lyle W. BakerJaime Jimenez-LopezXochiquetzal J. GeigerNabeel AslamKarger Publishersarticlemembranous glomerulonephritisanti-phospholipase-a2 receptor antibodiesmalignancyrenal cell carcinomanephrotic syndromeDiseases of the genitourinary system. UrologyRC870-923ENCase Reports in Nephrology and Dialysis, Vol 11, Iss 3, Pp 334-339 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
membranous glomerulonephritis anti-phospholipase-a2 receptor antibodies malignancy renal cell carcinoma nephrotic syndrome Diseases of the genitourinary system. Urology RC870-923 |
spellingShingle |
membranous glomerulonephritis anti-phospholipase-a2 receptor antibodies malignancy renal cell carcinoma nephrotic syndrome Diseases of the genitourinary system. Urology RC870-923 Lyle W. Baker Jaime Jimenez-Lopez Xochiquetzal J. Geiger Nabeel Aslam Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
description |
Membranous nephropathy (MN) is currently classified as either primary – often associated with positive anti-phospholipase-A2 receptor (PLA2R) autoantibodies – or as secondary – associated with malignancy, infection, medications, or autoimmune disease. We present a case of biopsy-proven MN with very high serum titer of anti-PLA2R autoantibodies in a patient with a synchronous diagnosis of poorly differentiated esophageal adenocarcinoma and renal cell carcinoma who presented with nephrotic syndrome. Based on the current classification, MN in the presence of active malignancy is diagnosed as secondary and unlikely to have positive anti-PLA2R autoantibodies. This raises several questions: whether this patient has secondary MN associated with malignancy and coincidentally discovered anti-PLA2R autoantibodies, primary MN due to anti-PLA2R autoantibodies with coincidentally discovered malignancy, or whether malignancy can induce the formation of anti-PLA2R autoantibodies that result in MN. This case report highlights the importance of age-appropriate cancer screening, even in patients with presumed primary MN and positive anti-PLA2R autoantibodies. |
format |
article |
author |
Lyle W. Baker Jaime Jimenez-Lopez Xochiquetzal J. Geiger Nabeel Aslam |
author_facet |
Lyle W. Baker Jaime Jimenez-Lopez Xochiquetzal J. Geiger Nabeel Aslam |
author_sort |
Lyle W. Baker |
title |
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
title_short |
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
title_full |
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
title_fullStr |
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
title_full_unstemmed |
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection |
title_sort |
malignancy-associated membranous nephropathy with positive anti-pla2r autoantibodies: coincidence or connection |
publisher |
Karger Publishers |
publishDate |
2021 |
url |
https://doaj.org/article/233a25bf3d4949f692b2b338038fcfc1 |
work_keys_str_mv |
AT lylewbaker malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection AT jaimejimenezlopez malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection AT xochiquetzaljgeiger malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection AT nabeelaslam malignancyassociatedmembranousnephropathywithpositiveantipla2rautoantibodiescoincidenceorconnection |
_version_ |
1718393729670184960 |